Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 1 (1)
P 2 (1)
P 4 (2)

Trial Status

Completed7
Recruiting5
Unknown4
Not Yet Recruiting3
Active Not Recruiting2
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT04695119Active Not Recruiting

Sepsis in the ICU-II

NCT07421726Completed

Controlled Terminal Reperfusion With Cold Preservation Solution in the cDCD III Donor

NCT05405426Not ApplicableActive Not Recruiting

Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

NCT07156656Phase 4Not Yet Recruiting

Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection

NCT07119411Not Yet Recruiting

ICU Background Early Awareness for Critical deterioratiON

NCT05872152Not ApplicableRecruitingPrimary

Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs

NCT06330610Not ApplicableRecruiting

Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit

NCT03547232Phase 4Recruiting

Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)

NCT06566638Not ApplicableNot Yet Recruiting

Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis

NCT06781502RecruitingPrimary

Electronic Archive of Internal Medicine for the Treatment of Severe Organ Failure and Liver Transplantation-MITIGO

NCT06452966Not ApplicableRecruitingPrimary

The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients

NCT03825250Phase 1Unknown

The Val-CARD Trial

NCT04015973Not ApplicableUnknown

The PRE-OP ENERGY Trial

NCT05972980Completed

Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients

NCT04772703Completed

DNA Damage in Critically Ill COVID-19 Patients

NCT04732481CompletedPrimary

Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.

NCT03167788Phase 2WithdrawnPrimary

Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery

NCT03075605Completed

PROOF: Pancreatitis-associated Risk Of Organ Failure

NCT04502511Unknown

Heterogeneity of Critical Illness: a Cohort Study

NCT03933930Not ApplicableWithdrawnPrimary

Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.

Scroll to load more

Research Network

Activity Timeline